69 related articles for article (PubMed ID: 2152392)
1. Peroral treatment with ciprofloxacin of patients with spinal cord lesion and bacteriuria caused by multiply resistant bacteria.
Pedersen SS; Hørbov S; Biering-Sørensen F; Høiby N
Paraplegia; 1990 Jan; 28(1):41-7. PubMed ID: 2152392
[TBL] [Abstract][Full Text] [Related]
2. A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Dow G; Rao P; Harding G; Brunka J; Kennedy J; Alfa M; Nicolle LE
Clin Infect Dis; 2004 Sep; 39(5):658-64. PubMed ID: 15356779
[TBL] [Abstract][Full Text] [Related]
3. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
[TBL] [Abstract][Full Text] [Related]
6. Uropathogens and empiric antibiotics for the treatment of urinary tract infections in spinal cord injured patients at rehabilitation center, Thai Red Cross Society during 2001 to 2005.
Tantisiriwat N; Kittisomprayoonkul W; Sukonthamarn K; Unhasuta C; Suankratay C; Tantisiriwat W; Aksaranugraha S
J Med Assoc Thai; 2007 Nov; 90(11):2482-6. PubMed ID: 18181338
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
9. A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin.
Wazait HD; Patel HR; van der Meulen JH; Ghei M; Al-Buheissi S; Kelsey M; Miller RA; Emberton M
BJU Int; 2004 Nov; 94(7):1048-50. PubMed ID: 15541126
[TBL] [Abstract][Full Text] [Related]
10. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
[TBL] [Abstract][Full Text] [Related]
11. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
Davis C
Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin in severe infections.
Aswapokee N; Pruksachatvuthi S; Aswapokee P
J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
[TBL] [Abstract][Full Text] [Related]
13. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
[TBL] [Abstract][Full Text] [Related]
14. Eradication of urinary tract infection following spinal cord injury.
Waites KB; Canupp KC; DeVivo MJ
Paraplegia; 1993 Oct; 31(10):645-52. PubMed ID: 8259327
[TBL] [Abstract][Full Text] [Related]
15. [Pyuria, bacteriuria and urinary tract infections in hospitalized patients with spinal cord injuries].
Tysnes OB; Krokeide M; Bjerke L; Digranes A
Tidsskr Nor Laegeforen; 1996 Aug; 116(18):2172-4. PubMed ID: 8801659
[TBL] [Abstract][Full Text] [Related]
16. The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research consensus statement. January 27-29, 1992.
SCI Nurs; 1993 Jun; 10(2):49-61. PubMed ID: 8351506
[TBL] [Abstract][Full Text] [Related]
17. Oral ciprofloxacin in resistant urinary tract infections.
Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim-sulfamethoxazole prophylaxis against urinary tract infection in the chronic spinal cord injury patient.
Sandock DS; Gothe BG; Bodner DR
Paraplegia; 1995 Mar; 33(3):156-60. PubMed ID: 7784119
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
20. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in the Gaza Strip.
Astal ZE
Singapore Med J; 2005 Sep; 46(9):457-60. PubMed ID: 16123829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
